Table 2 Clinicopathological features and disease-free survival

Age

0.67*

0.15–2.89

0.52*

0.10–2.62

0.426

Histology

 NST vs others

0.57

0.25–1.28

Residual tumour size in breast

5.30*

1.68–14.44

4.11*

1.01–14.86

0.048

Residual tumour in lymph node

 Positive vs negative

2.98

1.62–5.49

2.54

1.29–5.09

0.007

Tumour grade

 High vs low

1.27

0.69–2.31

1.33

0.63–2.75

0.443

Ki67

3.22*

0.91–10.67

ER

 Positive vs negative

0.91

0.49–1.67

0.66

0.26–1.62

0.360

PgR

 Positive vs negative

1.04

0.57–1.88

HER2

 Positive vs negative

0.93

0.48–1.82

1.04

0.45–2.34

0.920

TIL

0.96*

0.32–2.50

1.22*

0.38–3.52

0.730

CD8

1.81*

0.30–8.60

CD138

0.36*

0.06–1.63